Joseph H. Krushinski

1.6k citations

38 papers · 1.2k indexed · h-index 18

Organic Chemistry top 5%
Molecular Biology
Cellular and Molecular Neuroscience top 5%
Pharmacology top 5%
Psychiatry and Mental health top 10%

Co-authors: David W. Robertson David T. Wong Leroy R. Reid J. David Leander R W Fuller Frank P. Bymaster John M. Schaus Harve Wilson
Topics: Neurotransmitter Receptor Influence on Behavior (8 papers)Pharmacological Receptor Mechanisms and Effects (6 papers)Synthesis and Biological Evaluation (5 papers)
Cited by: Cellular and Molecular Neuroscience Pharmacology Toxicology
Journals: The FASEB Journal Journal of Medicinal Chemistry Critical Care Medicine
Partner nations: United States Sweden United Kingdom

In The Last Decade

Joseph H. Krushinski

35 papers receiving 1.1k citations

Peers

Countries citing papers authored by Joseph H. Krushinski

Since Specialization

Citations

This map shows the geographic impact of Joseph H. Krushinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph H. Krushinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph H. Krushinski more than expected).

Fields of papers citing papers by Joseph H. Krushinski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph H. Krushinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph H. Krushinski. The network helps show where Joseph H. Krushinski may publish in the future.

Co-authorship network of co-authors of Joseph H. Krushinski

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph H. Krushinski. A scholar is included among the top collaborators of Joseph H. Krushinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph H. Krushinski. Joseph H. Krushinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and Efficiency of Intravenous Push Lacosamide Administration 2018 ·Neurocritical Care ·(unknown),(unknown),Khalid Alsherbini,Joseph H. Krushinski,G. Morgan Jones	27
2	Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT1F receptor agonists: Evolution from bicyclic to monocyclic cores 2015 ·Bioorganic & Medicinal Chemistry Letters ·Deyi Zhang,María‐Jesús Blanco,Bai‐Ping Ying,(unknown),Sidney Liang,Frantz Victor,Qi Chen,Joseph H. Krushinski,Sandra Filla,(unknown),Brian M. Mathes,Michael P. Cohen,(unknown),David L. Nelson,David B. Wainscott,(unknown),Wendy H. Gough,John M. Schaus,Yao‐Chang Xu	5
3	Pharmacological characterization of the cannabinoid CB1 receptor PET ligand ortholog, [3H]MePPEP 2010 ·European Journal of Pharmacology ·Todd M. Suter,(unknown),(unknown),John M. Schaus,Joseph H. Krushinski,Michael A. Statnick,Christian C. Felder	4
4	The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain 2007 ·Neuropsychopharmacology ·Fumihiko Yasuno,Amira K. Brown,Sami S. Zoghbi,Joseph H. Krushinski,Eyassu Chernet,J. Tauscher,John M. Schaus,Lee A. Phebus,(unknown),Christian C. Felder,Robert L. Gladding,Jinsoo Hong,Christer Halldin,Victor W. Pike,Robert B. Innis	63
5	Indoloxypropanolamine analogues as 5-HT1A receptor antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Joseph H. Krushinski,John M. Schaus,(unknown),David O. Calligaro,David L. Nelson,(unknown),David B. Wainscott,David T. Wong	10
6	[3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brain 2005 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Virginia L. Lucaites,Joseph H. Krushinski,John M. Schaus,James E. Audia,David L. Nelson	35
7	[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties 2005 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·David B. Wainscott,Joseph H. Krushinski,James E. Audia,John M. Schaus,John M. Zgombick,Virginia L. Lucaites,David L. Nelson	19
8	Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Deyi Zhang,(unknown),Joseph H. Krushinski,Sidney Liang,Bai‐Ping Ying,(unknown),Sean R. Dinn,David B. Wainscott,(unknown),Wendy H. Gough,David L. Nelson,John M. Schaus,Yao‐Chang Xu	15
9	Duloxetine (Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake 2003 ·Bioorganic & Medicinal Chemistry Letters ·F.P. Bymaster,(unknown),Jeremy Findlay,P. T. Gallagher,Joseph H. Krushinski,S.N. Mitchell,David W. Robertson,David C. Thompson,Louise Wallace,David T. Wong	93
10	Characterization of type I 5α-reductase activity in DU145 human prostatic adenocarcinoma cells 1996 ·The Journal of Steroid Biochemistry and Molecular Biology ·Martin Kaefer,James E. Audia,Nicholas Bruchovsky,Robin L. Goode,(unknown),(unknown),Joseph H. Krushinski,Chung Lee,Christopher P. Steidle,Debra M. Sutkowski,Blake Lee Neubauer	26
11	(R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake 1995 ·Life Sciences ·Donald R. Gehlert,Susan K. Hemrick-Luecke,Douglas A. Schober,Joseph H. Krushinski,J. Jeffry Howbert,David W. Robertson,David T. Wong,Ray W. Fuller	17
12	Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain 1995 ·Neurochemistry International ·Donald R. Gehlert,Douglas A. Schober,Susan K. Hemrick-Luecke,Joseph H. Krushinski,J. Jeffry Howbert,David W. Robertson,Ray W. Fuller,Dawn M. Wong	32
13	Norfluoxetine Enantiomers as Inhibitors of Serotonin Uptake in Rat Brain 1993 ·Neuropsychopharmacology ·David T. Wong,Frank P. Bymaster,Leroy R. Reid,(unknown),Joseph H. Krushinski,David W. Robertson	85
14	LY248686, A New Inhibitor of Serotonin and Norepinephrine Uptake 1993 ·Neuropsychopharmacology ·David T. Wong,Frank P. Bymaster,(unknown),Leroy R. Reid,Joseph H. Krushinski,David W. Robertson	187
15	Synthesis and pharmacological evaluation of a major metabolite of ameltolide, a potent anticonvulsant 1991 ·Journal of Medicinal Chemistry ·David W. Robertson,(unknown),Joseph H. Krushinski,(unknown),C. John Parli,B D Potts,J. David Leander	6
16	Localization of ATP sensitive potassium channels in the rat brain using a novel radioligand, [125I]iodoglibenclamide 1990 ·European Journal of Pharmacology ·Donald R. Gehlert,Dale E. Mais,Susan L. Gackenheimer,Joseph H. Krushinski,David W. Robertson	23
17	Synthesis of a tritium-labeled indolidan analog and its use as a radioligand for phosphodiesterase-inhibitor cardiotonic binding sites 1989 ·Journal of Medicinal Chemistry ·David W. Robertson,Joseph H. Krushinski,Barbara G. Utterback,Raymond F. Kauffman	15
18	Imidazole-pyridine bioisosterism: comparison of the inotropic activities of pyridine- and imidazole-substituted 6-phenyldihydropyridazinone cardiotonics 1988 ·Journal of Medicinal Chemistry ·David W. Robertson,Joseph H. Krushinski,(unknown),(unknown)	11
19	The absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor 1988 ·Journal of Medicinal Chemistry ·David W. Robertson,Joseph H. Krushinski,R W Fuller,J. David Leander	137
20	SYNTHESIS OF 2-[4-METHOXY-2-[2-(METHYLSULFINYL)ETHOXY]PHENYL]-1H-IMIDAZO[4, 5-b]PYRIDINE, A POTENT NONGLYCOSIDE INHIBITOR OF Na⁺, K⁺-ATPASE 1988 ·Organic Preparations and Procedures International ·David W. Robertson,Joseph H. Krushinski	1

About Joseph H. Krushinski

Joseph H. Krushinski is a scholar working on Toxicology, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (8 papers), Pharmacological Receptor Mechanisms and Effects (6 papers) and Synthesis and Biological Evaluation (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (313 citations), Pharmacology (268 citations) and Toxicology (50 citations). Joseph H. Krushinski has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include David W. Robertson, David T. Wong, Leroy R. Reid, J. David Leander, R W Fuller, Frank P. Bymaster, John M. Schaus, Harve Wilson, Raymond F. Kauffman and Frank P. Bymaster. Their work appears in journals such as The FASEB Journal, Journal of Medicinal Chemistry and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact